Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

103.98
BATS BZX Real-Time Price
As of 10:25am ET
 +1.02 / +0.99%
Today’s Change
43.86
Today|||52-Week Range
121.70
+42.22%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close102.96
Today’s open104.26
Day’s range102.72 - 104.46
Volume141,258
Average volume (3 months)950,347
Market cap$18.4B
Dividend yield--
Data as of 10:11am ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+7.30%
Earnings growth (next 5 years)+219.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...+0.49+0.57%
HSPHospira Inc+0.24+0.27%
MNKMallinckrodt Plc+1.25+1.03%
BMRNBiomarin Pharmaceuti...+2.76+1.91%
Data as of 10:26am ET, 07/31/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts